AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted Breakthroug...

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exc...

PCI expands bottling capacity Rockford, IL Commercial Packaging site to add nearly 100 million units of bottling line capacity. Philadelphia, USA – February 5, 20...

A dry eye therapy designed to compete with Allergan's Restasis failed to reach its primary endpoint in a head-to-head Phase 2a study, according to data released T...

After being injected into the joint, RTX binds to and ablates the nerve endings responsible for transmitting pain whil...

Finasteride, a generic hormone-blocking drug, was found to reduce the risk of prostate cancer by 25 percent in the landmark Prostate Cancer Prevention Trial (PCPT). L...

Sharp - a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed its relocation to its $23m state-of-the-art fa...